A change in the ART eligibility criteria for adults from a CD4+ T-lymphocyte count of 200 cells/μl to 350 cells/μl could have contributed to a decrease in extra-pulmonary tuberculosis, as the latter usually occurs in severely immunocompromised persons. The gene discussed is CD4; the disease is pulmonary tuberculosis.